• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝细胞癌。疾病现状与未来展望。

Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.

作者信息

Oon C J, Friedman M A

出版信息

Cancer Chemother Pharmacol. 1982;8(2):231-5. doi: 10.1007/BF00255489.

DOI:10.1007/BF00255489
PMID:6286165
Abstract

Primary hepatocellular cancer is a common and virulent malignancy found all over the world. New insights into this disease are being provided by evaluation of the impact of epidemiologic data (hepatitis viral exposure, race, sex, HLA typing, and environmental factors). An enhanced appreciation of the biochemical modulators of hepatocellular cancer metabolism is now also possible. The limited success of current therapies is far from satisfactory, but prospects for the future seem more varied and promising than ever before.

摘要

原发性肝细胞癌是一种在全球范围内常见且恶性程度高的肿瘤。对流行病学数据(肝炎病毒暴露、种族、性别、人类白细胞抗原分型和环境因素)影响的评估为该疾病带来了新的见解。目前,人们对肝细胞癌代谢的生化调节因子也有了更深入的认识。当前治疗方法取得的有限成功远不能令人满意,但未来的前景似乎比以往任何时候都更加多样且充满希望。

相似文献

1
Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.原发性肝细胞癌。疾病现状与未来展望。
Cancer Chemother Pharmacol. 1982;8(2):231-5. doi: 10.1007/BF00255489.
2
Epidemiology of hepatocellular carcinoma.肝细胞癌的流行病学
Gastroenterol Clin North Am. 1987 Dec;16(4):545-51.
3
Viral hepatitis and hepatocellular carcinoma.病毒性肝炎与肝细胞癌。
Gastroenterol Clin North Am. 1994 Sep;23(3):567-79.
4
Hepatocellular carcinoma: status in the era of liver transplantation.肝细胞癌:肝移植时代的现状
J Okla State Med Assoc. 2009 Dec;102(12):355-61.
5
[Hepatocellular carcinoma--epidemiology and treatment].[肝细胞癌——流行病学与治疗]
Przegl Epidemiol. 2006;60(4):731-40.
6
The relationship between hepatocellular carcinoma and hepatitis B and C virus.肝细胞癌与乙型和丙型肝炎病毒之间的关系。
Clin Adv Hematol Oncol. 2016 Feb;14(2):96-8.
7
Hepatocellular carcinoma in sub-Saharan (tropical) Africa.撒哈拉以南(热带)非洲地区的肝细胞癌
Acta Med Hung. 1991;48(3-4):177-87.
8
The impact of viral hepatitis on the morbidity and mortality of chronic liver disease and hepatocellular carcinoma in Ethiopia.病毒性肝炎对埃塞俄比亚慢性肝病和肝细胞癌发病率及死亡率的影响。
Ethiop Med J. 1992 Apr;30(2 Suppl):i-iv.
9
Epidemiology, risk factors, and natural history of hepatocellular carcinoma.肝细胞癌的流行病学、危险因素及自然史
Ann N Y Acad Sci. 2002 Jun;963:13-20. doi: 10.1111/j.1749-6632.2002.tb04090.x.
10
The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis.乙型和丙型肝炎感染进展为慢性肝病和肝细胞癌:流行病学与发病机制
Med Clin North Am. 2005 Mar;89(2):371-89. doi: 10.1016/j.mcna.2004.08.014.

引用本文的文献

1
Detection of hepatitis B virus surface antigen mutants in paraffin-embedded hepatocellular carcinoma tissues.石蜡包埋肝细胞癌组织中乙型肝炎病毒表面抗原突变体的检测
Virus Genes. 2000;20(3):263-7. doi: 10.1023/a:1008100930584.
2
A risk-benefit assessment of tamoxifen therapy.他莫昔芬治疗的风险效益评估。
Drug Saf. 1993 May;8(5):381-97. doi: 10.2165/00002018-199308050-00005.
3
Treatment of primary liver cancer in Singapore. A review of 3200 cases seen between January 1, 1977, and July 31, 1987.新加坡原发性肝癌的治疗。对1977年1月1日至1987年7月31日期间诊治的3200例病例的回顾。

本文引用的文献

1
Influence of adrenocortical, androgenic, and anabolic hormones on the development of carcinoma and cirrhosis of the liver in A x C rats fed N-2-fluorenyldicetamide.
J Natl Cancer Inst. 1961 Sep;27:559-95.
2
Hypoglycemia in primary carcinoma of the liver.原发性肝癌中的低血糖症。
AMA Arch Intern Med. 1956 Dec;98(6):720-31. doi: 10.1001/archinte.1956.00250300038006.
3
Influence of sex and sex hormones on development of hepatomas and other hepatic lesions in strain AX C rats ingesting 2-diacetylaminofluorene.性别和性激素对摄入2-二乙氨基芴的AX C品系大鼠肝癌及其他肝脏病变发展的影响。
Cancer Chemother Pharmacol. 1989;23 Suppl:S13-6. doi: 10.1007/BF00647231.
4
Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions.新加坡肝细胞癌治疗后的长期生存情况:评估惠福仁在预防高危癌前病变中的作用。
Cancer Chemother Pharmacol. 1992;31 Suppl:S137-42. doi: 10.1007/BF00687123.
J Natl Cancer Inst. 1956 Feb;16(4):927-49.
4
Epidemiology or primary liver cancer in Singapore.新加坡原发性肝癌的流行病学
Ann Acad Med Singap. 1980 Apr;9(2):193-5.
5
Inhibition of local and metastatic hepatoma growth and prolongation of survival after induction of hypothyroidism.甲状腺功能减退诱导后,对局部和转移性肝癌生长的抑制及生存期的延长。
Cancer Res. 1981 Aug;41(8):3040-5.
6
Immunological evaluation of asymptomatic carriers of hepatitis B virus.乙型肝炎病毒无症状携带者的免疫学评估。
Clin Exp Immunol. 1981 Apr;44(1):63-7.
7
Hepatitis B surveillance in Singapore.新加坡的乙肝监测
Ann Acad Med Singap. 1980 Apr;9(2):136-41.
8
Adriamycin in the treatment of resectible and irresectible primary hepatocellular carcinoma.阿霉素治疗可切除和不可切除的原发性肝细胞癌。
Ann Acad Med Singap. 1980 Apr;9(2):256-9.
9
A pilot study on the screening of primary hepatocellular carcinoma in selected high risk groups in the population using multiple tumour markers.一项利用多种肿瘤标志物对人群中选定高危组原发性肝细胞癌进行筛查的初步研究。
Ann Acad Med Singap. 1980 Apr;9(2):240-4.
10
Primary hepatocellular carcinoma in the Asian Pacific region.亚太地区的原发性肝细胞癌
Ann Acad Med Singap. 1980 Apr;9(2):190-2.